Outcomes in patients with osteoarthritis treated with minimally invasive surgery vs a conventional posterior approach in total hip arthroplasty (hip replacement)

Functional and radiographic outcomes after Superpath minimally invasive approach vs conventional posterior approach in total hip arthroplasty: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN63687167

Enrollment

Registered

2020-05-13

Start date

2017-10-15

Completion date

Unknown

Last updated

2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total hip arthroplasty Musculoskeletal Diseases

Interventions

Patients presenting with primary hip osteoarthritis and requiring arthroplasty will be randomized to one of two groups. Randomization will be done using a random number generator and sealed envelopes.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Symptomatic primary osteoarthritis severe enough to warrant total hip arthroplasty

Exclusion criteria

Exclusion criteria: 1. Femoral neck fracture 2. Acetabulum fracture

Design outcomes

Primary

Measure	Time frame
Harris hip score and Hip disability and osteoarthritis outcome score at baseline, 6 weeks and up to 6 months postoperatively	—

Secondary

Measure	Time frame
1. Radiograpic prosthesis positioning (cup abduction angle, stem alignment) measured using X-ray one day after operation 2. Perioperative parameters (Hb, transfusion rate, length of stay, NRS score, operation time) at the time of operation	—

Countries

Belgium

Contacts

Public ContactWouter Schroven

wouter.schroven@student.kuleuven.be+32 477829556

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026